Brief: Kintor Pharmaceutical Gets Approval For Investigational New Drug Application Of Pyrilutamide Gel
18/09/2020 08:08
Sept 18 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK :
* GOT APPROVAL FOR INVESTIGATIONAL NEW DRUG APPLICATION OF
PYRILUTAMIDE (KX-826) GEL FROM NMPA
Source text for Eikon: ID:nHKS3hGqPn
Further company coverage: 9939.HK
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint